SCHEMBL11998342

SCHEMBL11998342

Cc1ccc2c(c1)OCC(C)(C)CO2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.45
SLC6A2 P23975 1/20 0.45
HTR2C P28335 1/20 0.45
HTR2B P41595 1/20 0.45
SIGMAR1 Q99720 1/20 0.45
MMP12 P39900 1/20 0.41
ALDH1A1 P00352 4/20 0.39
MAPT P10636 4/20 0.39
GAA P10253 2/20 0.39
HSD17B10 Q99714 1/20 0.39
KDM4E B2RXH2 3/20 0.38
MEN1 O00255 2/20 0.38
USP2 O75604 2/20 0.38
CASP1 P29466 2/20 0.38
HBB P68871 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 6/20 0.38
RAB9A P51151 5/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ACACB O00763 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14943764 0.80 HTR2B (0.43) HTR1ASLC6A2HTR2CHTR2BSIGMAR1
SCHEMBL5985680 0.79 HTR2B (0.39) HTR1ASLC6A2HTR2CHTR2BSIGMAR1
SCHEMBL11926948 0.79 HTR1A (0.42) HTR1ASLC6A2HTR2CHTR2BSIGMAR1
SCHEMBL30968 0.78 ALDH1A1 (0.55) ALDH1A1MAPTGAAHSD17B10KDM4E
SCHEMBL30452062 0.78 ALDH1A1 (0.55) ALDH1A1MAPTGAAHSD17B10KDM4E
SCHEMBL11905 0.78 MAPT (0.53) ALDH1A1MAPTGAAHSD17B10KDM4E
SCHEMBL3792549 0.78 CYP3A4 (0.61) HTR2BSIGMAR1ALDH1A1MAPTGAA
SCHEMBL256363 0.78 LMNA (0.55) MAPTGAAMEN1KMT2ANPC1
SCHEMBL3797296 0.78 ACACB (0.36) HTR1ASLC6A2HTR2CHTR2BSIGMAR1
SCHEMBL25513577 0.76 HTR1A (0.40) HTR1ASLC6A2HTR2CHTR2BSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9366906-B2 Photoreactive compounds ROLIC AG (CH) 2016-06-14 US disclosed
US-8835472-B2 Compounds, pharmaceutical compositions and uses thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-09-16 US disclosed
US-20140192305-A1 PHOTOREACTIVE COMPOUNDS ROLIC AG (CH) 2014-07-10 US disclosed
US-20120214785-A1 New compounds, pharmaceutical compositions and uses thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214785-A1 New compounds, pharmaceutical compositions and uses thereof ABCG2, PGA5, PDE6G HTR1A 3133/4885SLC6A2 2708/4885HTR2C 2687/4885
US-20140192305-A1 PHOTOREACTIVE COMPOUNDS PCNA, CRY1, CRY2 HTR1A 3096/4885SLC6A2 385/4885HTR2C 1775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.